Phosphorylation state and protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (immunofluorescence dataset 4 of 4) - Dataset (ID:20277)

Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Primary Antibody (488) Secondary Antibody (488) Protein Detected (488) Mean Fluorescence Intensity (488) Primary Antibody (647) Secondary Antibody (647) Protein 1 Detected (647) Protein 2 Detected (647) Protein 3 Detected (647) Protein 4 Detected (647) Mean Fluorescence Intensity (647) Plate Name Plate Well
COLO 858 Vemurafenib 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 300.75 NGFR rabbit IgG(H+L) / donkey NGFR 154.41
Colo858-P3
B5
A-375 Vemurafenib 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 154.17 NGFR rabbit IgG(H+L) / donkey NGFR 653.89
A375-P3
B5
WM-115 Vemurafenib I-BET 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 38.15 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 20.58
WM115-P1
D10
A-375 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 50.35 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 784.89
A375-P2
C10
A-375 Vemurafenib I-BET 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 72.95 NGFR rabbit IgG(H+L) / donkey NGFR 360.57
A375-P3
D10
WM-115 Vemurafenib 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 84.16 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 24.48
WM115-P1
B5
WM-115 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 15.33 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) -3.35
WM115-P1
C10
WM-115 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 19.02 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) -3.07
WM115-P1
B10
COLO 858 Vemurafenib (+)-JQ1 1.000 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 262.01 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 606.14
Colo858-P4
G5
WM-115 Vemurafenib 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 91.71 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 223.95
WM115-P2
C5
COLO 858 Vemurafenib (+)-JQ1 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 315.16 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 53.10
Colo858-P1
F5
A-375 Vemurafenib 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 150.75 NGFR rabbit IgG(H+L) / donkey NGFR 648.96
A375-P3
C5
COLO 858 Vemurafenib (+)-JQ1 1.000 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 347.98 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 214.70
Colo858-P2
G5
COLO 858 Vemurafenib I-BET 1.000 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 237.29 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 37.21
Colo858-P1
E10
COLO 858 Vemurafenib (+)-JQ1 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 200.09 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 673.63
Colo858-P4
F5
COLO 858 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 216.87 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 726.06
Colo858-P2
C10
COLO 858 Vemurafenib (+)-JQ1 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 331.50 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 300.70
Colo858-P2
F5
COLO 858 Vemurafenib Belinostat 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 233.75 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 50.00
Colo858-P1
D5
A-375 Vemurafenib 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 201.24 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 467.51
A375-P2
B5
COLO 858 Vemurafenib I-BET151 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 194.47 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 371.62
Colo858-P4
F10
COLO 858 Vemurafenib I-BET151 1.000 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 123.61 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 308.59
Colo858-P4
G10
A-375 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 46.71 NGFR rabbit IgG(H+L) / donkey NGFR 585.27
A375-P3
C10
COLO 858 Vemurafenib I-BET 1.000 1.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 293.26 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 48.43
Colo858-P1
D10
A-375 Vemurafenib 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 185.44 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 49.39
A375-P1
C5
COLO 858 Vemurafenib Belinostat 1.000 1.000
uM
48
hr
2 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 273.84 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 62.52
Colo858-P1
E5